Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Role of Redox Status of Patients With Autoimmune Rheumatic Diseases on Disease Progression: An Epidemiological Study

NCT07536529 is registered in ClinicalTrials.gov with University of Thessaly as lead sponsor.

NCT NCT07536529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07536529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Role of Redox Status of Patients With Autoimmune Rheumatic Diseases on Disease Progression: An Epidemiological Study
Lead sponsor
University of Thessaly
Phase
Observational
Overall status
Recruiting
Start date
October 6, 2025
Completion date
October 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis (as), inflammatory joint diseases, psoriatic arthritis (psa), rheumatoid arthritis (ra)